Avastin bevacizumab: Postmarketing study data

There were no significant differences in the risk of myocardial infarction (MI) or ischemic cerebrovascular accident between treatment groups. The authors of the study said the data suggest differences in the safety profiles

Read the full 339 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE